|
End-of-day quote
Shanghai S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 9.400 CNY | -2.29% |
|
-6.75% | -13.04% |
| Market Cap | 5.45B 812M 714M 675M 612M 1.15B 77.93B 1.16B 8.08B 3.12B 39.77B 3.05B 2.98B 128B | P/E 2024 |
20.4x | P/E 2025 | 46.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.95B 737M 648M 613M 556M 1.04B 70.74B 1.05B 7.34B 2.83B 36.1B 2.77B 2.71B 116B | EV / Sales 2024 |
0.41x | EV / Sales 2025 | 0.56x |
| Free-Float |
24.73% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.29% | ||
| 1 week | -6.75% | ||
| Current month | -7.02% | ||
| 1 month | -8.83% | ||
| 3 months | +21.13% | ||
| 6 months | -6.19% | ||
| Current year | -13.04% |
| 1 week | 9.37 |  | 10.07 |
| 1 month | 9.17 | | 10.65 |
| Current year | 7.54 | | 13.16 |
| 1 year | 7.54 | | 18.13 |
| 3 years | 4.96 | | 18.13 |
| 5 years | 4.96 | | 18.13 |
| 10 years | 4.88 | | 18.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CEO | Chief Executive Officer | 57 | 2016-09-25 |
Ping Guan
DFI | Director of Finance/CFO | 54 | 2022-04-06 |
Rui Qu
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Dong Zhu
CHM | Chairman | 57 | 2023-12-14 |
Shi Wei Yin
BRD | Director/Board Member | 51 | 2023-12-25 |
Dan Guo
BRD | Director/Board Member | 56 | 2023-12-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | -6.75% | +19.59% | +19.59% | 831M | |
| -1.19% | -3.40% | +12.59% | +93.71% | 101B | |
| +0.03% | -2.42% | +43.32% | +150.90% | 50.99B | |
| -0.20% | -0.20% | -14.83% | +270.29% | 20.76B | |
| -0.81% | -1.24% | -11.43% | -12.11% | 7.93B | |
| +3.68% | +0.97% | -35.25% | -36.03% | 6.81B | |
| -0.44% | +1.72% | +1.30% | +17.65% | 6.79B | |
| -0.74% | -1.60% | -19.40% | -34.85% | 5.92B | |
| +0.06% | +0.12% | -2.65% | +23.01% | 4.96B | |
| -2.55% | -5.61% | +13.61% | +16.60% | 4.11B | |
| Average | -0.55% | +0.33% | +0.68% | +50.88% | 21.01B | |
| Weighted average by Cap. | -0.84% | -1.81% | +13.30% | +107.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.05B 1.5B 1.32B 1.24B 1.13B 2.12B 144B 2.13B 14.9B 5.76B 73.31B 5.62B 5.5B 236B | 10.38B 1.55B 1.36B 1.29B 1.17B 2.19B 148B 2.2B 15.39B 5.95B 75.72B 5.8B 5.68B 243B |
| Net income | 213M 31.77M 27.94M 26.42M 23.96M 45M 3.05B 45.26M 316M 122M 1.56B 119M 117M 5B | 134M 19.93M 17.53M 16.58M 15.04M 28.24M 1.91B 28.41M 199M 76.67M 976M 74.84M 73.22M 3.14B |
| Net Debt | -200M -29.74M -26.16M -24.74M -22.44M -42.13M -2.85B -42.38M -296M -114M -1.46B -112M -109M -4.68B | -503M -74.92M -65.9M -62.31M -56.52M -106M -7.19B -107M -746M -288M -3.67B -281M -275M -11.79B |
Employees
2,735
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | CN¥9.400 | -2.29% | 8,239,978 |
| 26-09-24 | CN¥9.620 | -0.72% | 10,896,300 |
| 26-09-23 | CN¥9.690 | -4.06% | 11,967,700 |
| 26-09-22 | CN¥10.10 | +0.20% | 14,582,416 |
- Stock Market
- Stocks
- 600829 Stock
Select your edition
All financial news and data tailored to specific country editions
